Ash A. Alizadeh, MD/PhD

Employment

• Stanford University School of Medicine Professor of Medicine
  2021 - Present
• Stanford University Associate Professor
  2018 - 2021
• Stanford University School of Medicine Assistant Professor
  2010 - 2018

Education

• Stanford University School of Medicine Post-Doctoral Training (Ronald Levy and Irv Weissman, mentors)
  2007 - 2009
• Stanford University School of Medicine Fellowship in Hematology and Medical Oncology
  2006 - 2009
• Stanford University School of Medicine Internship/Residency
  2004 - 2006
• UCSF Faculty Fellow, Sandler Fellows Program
  2003 - 2004
• Stanford University School of Medicine MD, PhD (Biophysics)
  1994 - 2003
• UCLA Life Sciences B.S., Biochemistry (Magna cum laude)
  1989 - 1994

Projects & Funding

Projects & funding information is unavailable.

Publications (793)

• Harmonizing standards and resources for the medical genome
  Nature 2026 DOI: 10.1038/s41586-026-10621-5
  +Save
• Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma
  Blood Cancer Discovery 2026 DOI: 10.1158/2643-3230.BCD-25-0327
  +Save
• A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  Blood Cancer Discovery 2026 DOI: 10.1158/2643-3230.BCD-25-0138
  +Save
• Data from A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  2026 DOI: 10.1158/2643-3230.c.8239515
  +Save
• Figure S1 from A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  2026 DOI: 10.1158/2643-3230.31047105
  +Save
• Figure S2 from A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  2026 DOI: 10.1158/2643-3230.31047099
  +Save
• Figure S3 from A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  2026 DOI: 10.1158/2643-3230.31047096
  +Save
• Figure S4 from A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  2026 DOI: 10.1158/2643-3230.31047093
  +Save
• Figure S5 from A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  2026 DOI: 10.1158/2643-3230.31047090
  +Save
• Table S1 from A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma
  2026 DOI: 10.1158/2643-3230.31047087
  +Save